** Stifel Financial SF.N stock down 2.9% after co ordered to pay $132.5 mln for misrepresenting risk of complex structured notes
** Financial Industry Regulatory Authority arbitration panel awarded $26.5 mln in compensatory damages, $79.5 mln in punitive damages, and $26.5 mln for legal fees to the Jannetti family
** Value of the notes was linked to the SPDR S&P Biotech ETF XBI.P and stocks including DocuSign DOCU.O, Dynatrace DT.N, Palantir Technologies PLTR.O and Twilio TWLO.N
** Stifel plans to appeal, arguing the Jannettis were experienced investors who understood risks and only complained after losses
** SF's stock has declined about 13% YTD, compared to a 6% fall in S&P 500 .SPX
** Stock is about 23% below its 52-week intraday high of $120.27 reached on Jan. 30, 2025
** Stock recently traded at 11 times expected earnings, in line with its 5-year avg forward PE of 11, per LSEG data
(Reporting by Noel Randewich)
((noel.randewich@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。